standard business process (S&OP), in close cooperation with the Performance Manager, Supply chain Specialist, Integrated Operations, Sales and the CCBT.Responsibilities• Manage the predictive model• Responsible for both base and promotional planning (0-18 months)• Responsible for promotional predictive
model is a plus;- Experience with IQVIA MI data model is a plus.Other information- Temporary project with expected end date of 31st of March; - Fulltime onsite position of 40 hours a week.Are you interested and do want to apply for this role, please fill out your application via the apply button below
tools (TPM & ARO model) so that they can be translated correctly in the global forecasting tool.In the meantime, they search & provide sustainable solutions to automatize or facilitate the conversion of those exceptions in value in the quarterly forecast. They work therefore closely with Customer
organisation, based in Zuid-Holland Netherlands.The CompanyTransnational consumer goods company.Role DescriptionThe Exception Manager is working close with the Forecast Excellence Officers, in order to manage all forecasting flows still happening outside the defined tools (TPM & ARO model) so that they can be
studies- Create and maintain project plan to ensure timely clinical study start - Create and maintain study forecast for finished drug product in applicable systems- Design optimal packaging configuration for finished drug product and design cost efficient (re)supply model to distribute finished drug
geregistreerd•Heb je ervaringsdeskundigheid en bekendheid met het 12 stappen model (is een pré (min. 4 jr. clean & sober))•Heb je werkervaring in de verslavingszorg•Beschik je over een gezonde dosis zelfreflectie •Heb je ervaring met het uitvoeren van de functie regiebehandelaar•Ben je 36 uur beschikbaar in de
Design cost efficient (re)supply model to distribute finished drug product by taken into account risk analysis and mitigation strategy- Ensure efficient and smooth hand-over to clinical demand and inventory planning team- Facilitate the phase in phase out strategy for new medicinal product introduction ...